Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
NCT04421248
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
Attention-Deficit/Hyperactivity Disorder (ADHD) is the most commonly diagnosed neurobehavioral disorder in childhood. Children with ADHD struggle in school due to problems with attention and high levels of impulsivity and hyperactivity. They are at substantially increased risk for long-term difficulties into adulthood, including academic underachievement, substance abuse, and criminal behavior.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Attention Deficit Hyperactivity Disorder Combined
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 8 to 12 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Donald Gilbert, MD, MS, FAAN, FAAP
- Last updated on ClinicalTrials.gov
- September 25, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Kennedy Krieger Institute · Baltimore, MD
Ohio · 1
- Cincinnati Children's Hospital Medical Center · Cincinnati, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.